$266 Million is the total value of Bronte Capital Management Pty Ltd.'s 11 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 30.0% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKB | Buy | BERKSHIRE HATHAWAY INC DELcl b new | $55,936,000 | -1.3% | 278,440 | +0.3% | 20.99% | -7.2% |
| HLF | Buy | HERBALIFE NUTRITION LTD | $49,976,000 | -9.5% | 943,128 | +0.7% | 18.76% | -14.9% |
| V | Buy | VISA INC | $43,817,000 | +18.6% | 280,538 | +0.2% | 16.44% | +11.6% |
| GOOGL | Buy | ALPHABET INCcap stk cl a | $35,078,000 | +13.2% | 29,806 | +0.5% | 13.16% | +6.5% |
| IBKR | Buy | INTERACTIVE BROKERS GROUP | $23,359,000 | -4.3% | 450,254 | +0.8% | 8.77% | -10.0% |
| GE | New | GENERAL ELECTRIC CO | $18,152,000 | – | 1,816,994 | +100.0% | 6.81% | – |
| WRLD | Buy | WORLD ACCEP CORP DEL | $15,997,000 | +15.4% | 136,575 | +0.8% | 6.00% | +8.6% |
| GOOG | ALPHABET INCcap stk cl c | $15,119,000 | +13.3% | 12,886 | 0.0% | 5.67% | +6.6% | |
| SQM | QUIMICA Y MINERA CHILEspon adr ser b | $5,857,000 | +0.4% | 152,369 | 0.0% | 2.20% | -5.6% | |
| KMT | Buy | KENNAMETAL INC | $2,080,000 | +56.3% | 56,596 | +41.5% | 0.78% | +47.1% |
| SSD | New | SIMPSON MANUFACTURING CO INC | $1,101,000 | – | 18,578 | +100.0% | 0.41% | – |
| TSLA | Exit | TESLA INCput | $0 | – | -60,400 | -100.0% | -4.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.